Trial Profile
A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin 250 mg and 500 mg in transient insomnia induced by a sleep phase advance
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Pfizer; Viatris Inc
- 02 Jun 2008 New trial record.